-
Sabre Insurance has reported stronger gross premiums while maintaining guidance. Written premiums reached £173.4m over nine months, with growth led by motor and motorcycle products.
-
Invinity has proposed raising at least £20m through new equity. The National Wealth Fund is expected to provide a minimum £10m cornerstone commitment, subject to conditions.
-
Cornish Metals has proposed £135m of financing for South Crofty. The conditional fundraising includes a Glencore investment and an offtake agreement, with production still a future target.
-
Company insolvencies declined in September, according to new official statistics. England and Wales recorded 1,882 cases, although compulsory liquidations increased as other procedures declined.
-
Emerald announced additional financing for its preventative healthcare service expansion. The company says £700,000 is an Innovate UK grant and £700,000 venture investment; independent October award confirmation remains outstanding.
-
Gamma delayed its takeover vote after limited shareholder proxy participation. Meetings moved to 2 November with less than 40% of eligible shares represented; the 1,120p cash terms remain unchanged.
-
Uber won dismissal of historical litigation brought by London drivers. The High Court held approximately £340m of claims time-barred without deciding the truth of the underlying allegations.
-
PwC reported global revenue growth despite subdued trading across EMEA. The professional services network reached $60.2bn in revenue, with constant-currency growth of 3.5% globally and 0.7% regionally.
-
Healthcare landlord PHP agreed a new partnership involving private hospitals. The proposed £700m venture with GIC covers 27 existing hospitals and is expected to release approximately £500m for debt repayment.
-
Merck agreed to buy British biotechnology company Silence Therapeutics outright. The approximately $1.3bn equity offer is conditional and would bring a clinical-stage RNA drug development platform into Merck’s healthcare division.